The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients

被引：0

作者：

Lin, Q. ^{[1
]}

Zhu, H. ^{[2
]}

Li, Y. ^{[1
]}

Zhang, H. ^{[3
]}

Ding, H. ^{[4
]}

Qian, J. ^{[5
]}

Han-Zhang, H. ^{[6
]}

Lin, J. ^{[6
]}

Xiang, J. ^{[6
]}

机构：

[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Peoples R China

[2] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China

[3] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China

[4] Ningbo Diagnost Pathol Ctr, Ningbo, Zhejiang, Peoples R China

[5] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Peoples R China

[6] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

Chinese; braf; NSCLC;

D O I：

10.1016/j.jtho.2019.08.735

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.01-20

引用

页码：S363 / S363

页数：1

共 50 条

[31] Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer
Laura Mezquita
Marianne Oulhen
Agathe Aberlenc
Marc Deloger
Mihaela Aldea
Aurélie Honore
Yann Lecluse
Karen Howarth
Luc Friboulet
Benjamin Besse
David Planchard
Françoise Farace
British Journal of Cancer, 2024, 130 : 682 - 693
[32] Clinical Characteristics and Outcome of Patients with Non-Small Cell Lung Cancer Harboring BRAF Mutations
Zhang, M.
Wang, H.
Ma, Z.
Zhang, X.
Li, P.
Yan, X.
Zhang, G.
Niu, Y.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S695 - S695
[33] Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation
Rittberg, Rebekah
Banerji, Shantanu
Green, Susan
Qing, Gefei
Dawe, David E.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
[34] Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
Tatsuki Ikoma
Mototsugu Shimokawa
Masahito Kotaka
Toshihiko Matsumoto
Hiroki Nagai
Shogen Boku
Nobuhiro Shibata
Hisateru Yasui
Hironaga Satake
BMC Cancer, 21
[35] BRAF V600E Mutation of Non-Small Cell Lung Cancer in Korean Patients
Ahn, Hyo Yeong
Lee, Chang Hun
Lee, Min Ki
Eom, Jung Seop
Jeong, Yeon Joo
Kim, Yeong Dae
Cho, Jeong Su
Lee, Jonggeun
Lee, So Jeong
Shin, Dong Hoon
Kim, Ahrong
MEDICINA-LITHUANIA, 2023, 59 (06):
[36] Class II and class III BRAF mutations in patients with advanced non-small cell lung cancer (NSCLC): Clinical characteristics, mutation patterns, and survival outcomes
Rasokat, Anna
Kron, Anna
Nogova, Lucia
Siebolts, Udo
Scharpenseel, Heather
Riedel, Richard
Michels, Sebastian Yves Friedrich
Fischer, Rieke Nila
Eisert, Anna
Prang, Darinka
Beckers, Frank
Kambartel, Kato
Kaminsky, Britta
Schaaf, Bernhard
Schulte, Wolfgang
Serke, Monika Heidi
Merkelbach-Bruse, Sabine
Buettner, Reinhard
Wolf, Juergen
Scheffler, Matthias
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[37] The incidence of BRAF mutation in non-small cell lung cancers is low in Korean patients
Kim, Ahrong
Ahn, Hyo Yeong
Lee, Chang Hun
Kim, Young Dae
Lee, Min Ki
Jeong, Yeon Joo
Lee, So Jeong
CANCER RESEARCH, 2020, 80 (16)
[38] BRAF-mutations in non-small cell lung cancer
Brustugun, Odd Terje
Khattak, Asma Malik
Tromborg, Anette Kjoshagen
Beigi, Marzieh
Beiske, Klaus
Lund-Iversen, Marius
Helland, Aslaug
LUNG CANCER, 2014, 84 (01) : 36 - 38
[39] Targeting BRAF mutations in non-small cell lung cancer
O'Leary, Connor Gerard
Andelkovic, Vladamir
Ladwa, Rahul
Pavlakis, Nick
Zhou, Caicun
Hirsch, Fred
Richard, Derek
O'Byrne, Kenneth
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1119 - 1124
[40] BRAF inhibitors in metastatic non-small cell lung cancer
Anguera, Georgia
Majem, Margarita
JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 589 - 592

← 1 2 3 4 5 →